PCM
AHCO icon

Prelude Capital Management’s AdaptHealth AHCO Stock Holding History

Prelude Capital Management’s Portfolio AHCO Stock Details AHCO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-11,441
Closed -$102K – 1268
2025
Q3 		$102K Buy
+11,441
New +$106K 0.01% 1054
2024
Q2 		– Sell
-23,347
Closed -$269K – 1194
2024
Q1 		$269K Buy
23,347
+5,125
+28% +$43.5K 0.01% 955
2023
Q4 		$133K Buy
+18,222
New +$144K 0.01% 1003
2022
Q1 		– Sell
-11,053
Closed -$270K – 1771
2021
Q4 		$270K Buy
+11,053
New +$259K 0.01% 1382
2021
Q2 		– Sell
-12,405
Closed -$456K – 1625
2021
Q1 		$456K Buy
12,405
+6,668
+116% +$236K 0.01% 947
2020
Q4 		$215K Buy
+5,737
New +$177K 0.01% 1078

Other funds holding AHCO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OCA
OEP Capital Advisors New York $194M AUM 9.78% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
SC
SkyKnight Capital San Francisco, California $107M AUM 9.69% 1-Year Est. Return
RP
Reinhart Partners Mequon, Wisconsin $4.38B AUM 55.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return

Prelude Capital Management's AHCO Position: Q4 2025 in Review

Prelude Capital Management sold out of AdaptHealth (AHCO) in Q4 2025, closing a stake of 11,441 shares — an estimated $102K sold.

Prelude Capital Management first reported a position in AHCO in Q4 2020 and held it in 6 quarters. The position peaked at $456K in Q1 2021. 231 funds tracked by Wall St. Rank hold AHCO as of Q4 2025.

  • Prelude Capital Management reported no remaining AdaptHealth position as of Q4 2025 after selling out during the quarter.
  • Prelude Capital Management sold 11,441 AdaptHealth shares in Q4 2025, an estimated $102K.
  • Prelude Capital Management first reported a position in AdaptHealth in Q4 2020 and held it in 6 quarters.
  • Prelude Capital Management's AdaptHealth position peaked at $456K in Q1 2021.
  • 231 funds tracked by Wall St. Rank held AdaptHealth as of Q4 2025.

Based on Prelude Capital Management's 13F filing for Q4 2025, filed 17 Feb 2026.